Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1292-1299

  Blanchet, Marie Renée ^a   Gold, Matthew ^a   Maltby, Steven ^a   Bennett, Jami ^a   Petri, Björn ^b   Kubes, Paul ^b   Lee, David M ^c,d   McNagny, Kelly M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; AUTOIMMUNE ARTHRITIS; AUTOIMMUNE DISEASE; BLOOD VESSEL PERMEABILITY; BONE MARROW; CELL TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; HEMATOPOIETIC CELL; MALE; MAST CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; BONE MARROW TRANSPLANTATION; CAPILLARY PERMEABILITY; CELL CULTURE; GENETICS; HOSPITALIZATION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD34; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CAPILLARY PERMEABILITY; CELLS, CULTURED; DISEASE PROGRESSION; IMMUNOPHENOTYPING; MALE; MAST CELLS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; SEVERITY OF ILLNESS INDEX;

EID: 77949316164     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900808     Document Type: Article

References (24)

1. Drew, E., H. Merkens, S. Chelliah, R. Doyonnas, and K. M. McNagny. 2002. CD34 is a specific marker of mature murine mast cells. Exp. Hematol. 10: 1211.
2. Rådinger, M., A. K. Johansson, B. Sitkauskiene, M. Sjöstrand, and J. Lötvall. 2004. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J. Allergy Clin. Immunol. 113: 1109-1116.
3. Schmidt, M., G. Sun, M. A. Stacey, L. Mori, and S. Mattoli. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171: 380-389. (Pubitemid 36745311)
4. Young, P. E., S. Baumhueter, and L. A. Lasky. 1995. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 85: 96-105.
5. Blanchet, M.-R., S. Maltby, D. J. Haddon, H. Merkens, L. Zbytnuik, and K. M. McNagny. 2007. CD34 facilitates the development of allergic asthma. Blood 110: 2005-2012.
6. Kannan, K., R. A. Ortmann, and D. Kimpel. 2005. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 12: 167-181. (Pubitemid 41375640)
7. Maccioni, M., G. Zeder-Lutz, H. Huang, C. Ebel, P. Gerber, J. Hergueux, P. Marchal, V. Duchatelle, C. Degott, M. van Regenmortel, et al. 2002. Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med. 195: 1071-1077.
8. Shin, K., M. F. Gurish, D. S. Friend, A. D. Pemberton, E. M. Thornton, H. R. Miller, and D. M. Lee. 2006. Lymphocyte-independent connective tissue mast cells populate murine synovium. Arthritis Rheum. 54: 2863-2871. (Pubitemid 44497765)
9. Nguyen, L.T., J. Jacobs, D. Mathis, and C. Benoist. 2007. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. Feb;56(2):509-520.
10. Chen, M., B. K. Lam, Y. Kanaoka, P. A. Nigrovic, L. P. Audoly, K. F. Austen, and D. M. Lee. 2006. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J. Exp. Med. 203: 837-842.
11. Chen, M., E. Boilard, P. A. Nigrovic, P. Clark, D. Xu, G. A. Fitzgerald, L. P. Audoly, and D. M. Lee. 2008. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis. Arthritis Rheum. 58: 1354-1365.
12. Binstadt, B. A., P. R. Patel, H. Alencar, P. A. Nigrovic, D. M. Lee, U. Mahmood, R. Weissleder, D. Mathis, and C. Benoist. 2006. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7: 284-292.
13. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
14. Nakano, T., Y. Kanakura, T. Nakahata, H. Matsuda, and Y. Kitamura. 1987. Genetically mast cell-deficient W/Wv mice as a tool for studies of differentiation and function of mast cells. Fed. Proc. 46: 1920-1923.
15. Fernández-Dueñas, V., O. Pol, P. García-Nogales, L. Hernández, E. Planas, and M. M. Puig. 2007. Tolerance to the antinociceptive and antiexudative effects of morphine in a murine model of peripheral inflammation. J. Pharmacol. Exp. Ther. 322: 360-368.
16. Zhou, J. S., W. Xing, D. S. Friend, K. F. Austen, and H. R. Katz. 2007. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J. Exp. Med. 204: 2797-2802.
17. Nigrovic, P. A., D. H. Gray, T. Jones, J. Hallgren, F. C. Kuo, B. Chaletzky, M. Gurish, D. Mathis, C. Benoist, and D. M. Lee. 2008. Genetic inversion in mast cell-deficient (W(sh)) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am. J. Pathol. 173: 1693-1701.
18. Drew, E., J. S. Merzaban, W. Seo, H. J. Ziltener, and K. M. McNagny. 2005. CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity 22: 43-57. (Pubitemid 40143450)
19. Kneilling, M., L. Hültner, B. J. Pichler, R. Mailhammer, L. Morawietz, S. Solomon, M. Eichner, J. Sabatino, T. Biedermann, V. Krenn, et al. 2007. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum. 56: 1806-1816.
20. Solomon, S., N. Rajasekaran, E. Jeisy-Walder, S. B. Snapper, and H. Illges. 2005. A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis. Eur. J. Immunol. 35: 3064-3073.
21. Sassetti, C., K. Tangemann, M. S. Singer, D. B. Kershaw, and S. D. Rosen. 1998. Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J. Exp. Med. 187: 1965-1975.
22. Nielsen, J. S., and K. M. McNagny. 2008. Novel functions of the CD34 family. J. Cell Sci. 121: 3683-3692.
23. Doyonnas, R., D. B. Kershaw, C. Duhme, H. Merkens, S. Chelliah, T. Graf, and K. M. McNagny. 2001. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J. Exp. Med. 194: 13-27.
24. Strilić, B., T. Kucera, J. Eglinger, M. R. Hughes, K. M. McNagny, S. Tsukita, E. Dejana, N. Ferrara, and E. Lammert. 2009. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev. Cell 17: 505-515.